These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17084273)

  • 1. Coronary plaque burden and cardiovascular risk factors: single-point versus serial assessment.
    von Birgelen C; Hartmann M
    J Am Coll Cardiol; 2006 Nov; 48(9):1914-5; author reply 1915-6. PubMed ID: 17084273
    [No Abstract]   [Full Text] [Related]  

  • 2. The mainstream hypothesis that LDL cholesterol drives atherosclerosis may have been falsified by non-invasive imaging of coronary artery plaque burden and progression.
    Ware WR
    Med Hypotheses; 2009 Oct; 73(4):596-600. PubMed ID: 19560285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small LDL and hsCRP as new risk factors for coronary artery disease.
    Brown CL; Garrett B; Superko HR
    J Med Assoc Ga; 2001 Dec; 90(4):11-6. PubMed ID: 11845678
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease.
    Tsimikas S
    Am J Cardiol; 2006 Dec; 98(11A):9P-17P. PubMed ID: 17126679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current diagnostic concepts to detect coronary artery disease in women.
    Stangl V; Witzel V; Baumann G; Stangl K
    Eur Heart J; 2008 Mar; 29(6):707-17. PubMed ID: 18272503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and coronary artery disease: ongoing debate.
    Celik T; Yuksel C; Iyisoy A; Isik E
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):e33-4. PubMed ID: 18472410
    [No Abstract]   [Full Text] [Related]  

  • 7. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How low to target LDL?
    Robinson JG; Davidson MH
    Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):414-5. PubMed ID: 16932325
    [No Abstract]   [Full Text] [Related]  

  • 9. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
    Chhatriwalla AK; Nicholls SJ; Wang TH; Wolski K; Sipahi I; Crowe T; Schoenhagen P; Kapadia S; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2009 Mar; 53(13):1110-5. PubMed ID: 19324254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe progression of coronary heart disease in a patient with elevated lipoprotein (a) level in spite of optimal LDL-C decrease].
    Fischer S; Julius U; Bergmann S; Hohensee H; Bornstein SR; Strasser RH
    Herz; 2007 Oct; 32(7):578-82. PubMed ID: 17972032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin and ezetimibe in addition to nonpharmacological risk factor modification for achieving new low-density lipoprotein cholesterol targets.
    Liska B; Khattab AA; Herrmann L; Abdel-Wahab M; Westphal R; Tölg R; Geist V; Richardt G
    Herz; 2008 Jul; 33(5):362-7. PubMed ID: 18773156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaques with high lipid burden: keeping the fat out of the fire.
    Roleder T; Suh W; Sharma R; Hecht H; Kovacic JC; Narula J; Kini AS
    Heart; 2013 Jul; 99(14):977-8. PubMed ID: 23349347
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis.
    Levinson SS
    Am J Clin Pathol; 2007 Mar; 127(3):449-55. PubMed ID: 17276939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines.
    Lloyd-Jones DM
    Curr Opin Lipidol; 2006 Dec; 17(6):619-25. PubMed ID: 17095905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?
    Holcombe SM; Brubaker PH
    J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LDL lowering--level and time. Maybe two equally important parameters for protection against arteriosclerosis].
    Herlitz J
    Lakartidningen; 2006 Oct 25-31; 103(43):3272-3. PubMed ID: 17117658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vulnerable plaque actual and future identification methods].
    Arias Mendoza A
    Arch Cardiol Mex; 2006; 76 Suppl 2():S229-32. PubMed ID: 17017107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
    Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.